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Summary: Causal inference methods have been developed for longitudinal observational study designs where
confounding is thought to occur over time. In particular, one may estimate and contrast the population mean
counterfactual outcome under specific exposure patterns. In such contexts, confounders of the longitudinal treatment-
outcome association are generally identified using domain-specific knowledge. However, this may leave an analyst with
a large set of potential confounders that may hinder estimation. Previous approaches to data-adaptive model selection
for this type of causal parameter were limited to the single time-point setting. We develop a longitudinal extension of
a collaborative targeted minimum loss-based estimation (C-TMLE) algorithm that can be applied to perform variable
selection in the models for the probability of treatment with the goal of improving the estimation of the population
mean counterfactual outcome under a fixed exposure pattern. We investigate the properties of this method through a
simulation study, comparing it to G-Computation and inverse probability of treatment weighting. We then apply the
method in a real data example to evaluate the safety of trimester-specific exposure to inhaled corticosteroids during
pregnancy in women with mild asthma. The data for this study were obtained from the linkage of electronic health
databases in the province of Quebec, Canada. The C-TMLE covariate selection approach allowed for a reduction of
the set of potential confounders, which included baseline and longitudinal variables.
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1. Introduction
Causal inference methods have been developed for longitudinal observational study designs
where confounding is thought to occur over time (Robins et al., 2000). In particular, several
methods estimate the expected counterfactual outcome under a fixed exposure regime (a
saturated marginal structural model Robins et al. 2000), including inverse probability of
treatment weighting (IPTW; Robins et al. 2000) and targeted minimum loss-based estima-
tion (TMLE; van der Laan and Rubin 2006; van der Laan and Gruber 2010). For a study
design where information is only collected at discrete time points, identifiability of this
parameter depends on the sequential ignorable treatment assignment assumption (Robins,
1998). Sequential ignorability is equivalent to the assumption that, at every time point,
treatment is essentially randomly assigned conditional on past measured information.
In such contexts, variables thought to satisfy sequential ignorability are generally iden-
tified using domain-specific knowledge (Robins, 2001; Hernán et al., 2002). However, this
may leave an analyst with a large set of potential confounders that may hinder estima-
tion (VanderWeele and Shpitser, 2011; Schnitzer et al., 2016). Various methods have been
developed to perform variable or model selection with the goal of improving estimation
of the causal parameter of interest (e.g. Crainiceanu et al. 2008; van der Laan and Gruber
2010; De Luna et al. 2011; Wang et al. 2012; Vansteelandt et al. 2012; Wilson and Reich
2014; Belloni et al. 2014). However, these methods have largely focused on the setting where
treatment is defined at a single time point. Machine learning methods have been used for the
estimation of the treatment model(s) in both longitudinal and non-longitudinal settings (e.g.
Neugebauer et al. 2007; Petersen et al. 2007; Ertefaie et al. 2017; Shortreed and Ertefaie 2017;
Benkeser et al. 2017; Schnitzer and Cefalu 2018). Recently, Shi et al. (2018) proposed using
the Dantzig selector based on the A-learning estimating function for high-dimensional co-
variate selection in dynamic treatment regimes.
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Collaborative targeted minimum loss-based estimation (C-TMLE; van der Laan and Gruber
2010; Gruber and van der Laan 2011; Ju et al. 2017) is a data-adaptive procedure that,
given an initial outcome model fit, constructs a targeted estimator by sequentially selecting
covariates into the model for treatment. The selection is made based on a loss function
criterion placed on the updated outcome model fit. Cross-validation is then used to determine
at what step the sequential selection terminates. By design, this procedure prioritizes the
selection of terms to reduce bias in the estimation of the target parameter while avoiding
terms that disproportionately increase the estimation variance. In this paper, we demonstrate
a novel extension of the single time point implementation of C-TMLE to the longitudinal
case for the estimation of the expected counterfactual outcome under fixed exposure regimen.
To ease understanding, we present the methodology in the context of a simplified example
where treatment and covariate information is collected at two time points and the outcome
measured at a third time point.
Our illustrative application involves drug safety during pregnancy. Asthma is a highly
prevalent chronic condition affecting pregnant women that can impact the health of the
mother and fetus (Murphy et al., 2011). The current standard of asthma treatment during
pregnancy is to continue medication because poorly controlled symptoms pose an acute
risk to the fetus and mother. However, many women with mild asthma stop taking med-
ication entirely due to the fear of increased risk to the pregnancy. Such women are indi-
cated to receive a low dose of inhaled corticosteroids (ICS; 0-250µg in Fluticasone equiva-
lent) (National Asthma Education and Prevention Program expert panel, 2005) versus none.
Our study evaluates the safety of taking low dose ICS during pregnancy for women with mild
asthma. While similar questions have been investigated using cohort data (Cossette et al.,
2013), a formal causal approach has yet to be taken. A particular challenge in this context is
to contrast treatment regimes in a population eligible for either option. In reality, treatment
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can vary over time due to fluctuating symptom severity and pregnancy complications. Pre-
vious work did not properly account for time-varying confounders (variables that can affect
future treatment and outcome) that are also influenced by previous treatment (Robins et al.,
2000). We investigate whether performing model selection with our proposed method changes
the study conclusion relative to several existing causal inference methods.
2. The delivery cohort dataset and structure
Our dataset is a cohort of singleton deliveries, defined as live or stillborn births occurring
past 20 weeks of gestation. It was constructed from a linkage of the Régie de l’assurance-
maladie du Québec andMaintenance et Exploitation des Données pour l’Étude de la Clientèle
Hospitalière databases. The former resource contains information on all medical services used
and medication prescriptions filled by Quebec residents on the public drug insurance plan.
The latter resource includes data from acute care hospitalizations. The derived database
contains all singleton deliveries in the province of Quebec, Canada between the years 1998-
2008 for women 6 45 years with at least one asthma diagnosis and at least one asthma
medication prescribed in the year before or during pregnancy. For inclusion, these women also
had to be covered by the Quebec public drug insurance plan in the year prior to and during
pregnancy (Cossette et al., 2013). Women taking theophylline, cromoglycate, nedocromil,
ketotifen, or long-acting β2-agonists without an ICS were excluded. A subsetted cohort of
women with mild asthma in the year prior to pregnancy was created (totaling 5881 deliveries).
For simplicity, the cohort was restricted to each woman’s first delivery (n = 5048).
For this investigation, we structured the data to contain two trimester-specific exposure
times. The dataset contains the following information about each subject:
• Pre-pregnancy covariates (L0) measured in the year prior to pregnancy, including maternal
characteristics (age at delivery, receiving social assistance, rural residence, and usage of
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beta-blockers), chronic maternal diseases (hypertension, diabetes, cystic fibrosis of the
pancreas, antiphospholipid syndrome, and cyanotic heart disease), and asthma control-
related variables (not controlled, use of short-acting β2-agonist, use of leukotriene receptor
antagonist, use of oral corticosteroids, use of intranasal corticosteroids, at least one hospi-
talization for asthma, and at least one emergency room visit for asthma),
• No exposure to ICS (A0 = 0) or low-dose ICS (6 250µg in Fluticasone equivalent daily;
A0 = 1) at the beginning of the first trimester,
• Covariates measured during the first trimester (L1), including chronic maternal diseases,
pathologies related to pregnancy (gestational diabetes, maternal infection, anemia, vaginal
bleeding, placental complications, placental abruption, and usage of beta-blockers), and
asthma control-related variables,
• Exposure status at the beginning of the second trimester (A1 = {0, 1}), and
• Three binary fetal growth outcomes (Y ), analyzed separately: low birth weight (LBW; <
2,500 g), premature birth (delivery before 37 weeks gestation), and small for gestational
age (SGA; below the 10th percentile) (Cossette et al., 2013). These outcomes are measured
at delivery, which can occur in the second or third trimester.
We are interested in estimating the mean outcome under exposure versus no exposure to low-
dose ICS at the beginning of the first two trimesters. The algorithm developed in the next
section aims to select covariates into a model predicting exposure with the goal of minimizing
empirical risk based on a loss function that specifically relates to the target parameter.
3. Methods
3.1 Identifiability of the target parameter
We observe randomly sampled longitudinal data O = (L0, A0, L1, A1, Y ) ∼ P0 where Lt
are covariates, At is a treatment indicator measured at times t = 0 and 1, and P0 is the
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true data-generating distribution, lying in some model M. Let Y be the outcome of interest,
measured at the end of pregnancy. Let Y a denote the counterfactual outcome under the fixed
treatment regime a and similarly let La01 represent the intermediate outcome under treatment
a0 at the first time point. Our goal is to estimate ψ = E(Y
a), the marginal mean outcome
under treatment regime a. For instance, if we consider the regime a = (a0, a1) = (1, 1), then
ψ represents the expected mean outcome in the population had all mothers received a low
daily dose of ICS in the first and second trimesters.
Let Q2(l1) = E(Y
a | L1 = l1) be the conditional expectation of the outcome under a
two time point fixed treatment regime (with an implicit dependence on a, the regime in
question) evaluated at some value l1. Let Q1(l0) = E(Y
a | L0 = l0) be the conditional
expectation of the outcome after fixing exposure in the first time point to the treatment
a0 at the baseline covariate value l0. In this setting, the sequential ignorability assumption
(needed for identifiability) requires
Y a⊥⊥A1 | A0 = a0, L1 and Y a⊥⊥A0 | L0, (1)
meaning that under a fixed regime, the counterfactual outcome is independent of past
treatment conditional on the observed past prior to each treatment. This is often thought
of as measuring all risk factors that affect subsequent treatment (Robins et al., 2000). In
the example, such variables include indicators of asthma control during the first trimester
(hospitalization and complementary controller mediation) which may directly affect fetal
growth and subsequent treatment as well as being affected by the previous treatment taken.
We also require positivity which implies that for all values of a0 that are being considered,
P (A0 = a0 | L0) > 0 almost surely (i.e. for all possible combinations of baseline covariates,
all treatments must be possible at the first time point). Similarly, for all a of interest, we
require that P (A1 = a1 | L1, A0 = a0) > 0 almost surely (Bang and Robins, 2005). For
the asthma example, this essentially means that all subjects must be eligible to follow all
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possible treatment regimens at all time points. Note that if these probabilities are estimated
to be (close to) zero, then we have (near) practical positivity violations, which can hinder
estimation. An additional assumption is no interference, such that one subject’s treatment
will not affect another’s counterfactual outcome under a fixed treatment. No interference is
credible in this case because asthma and fetal growth are not infectious, nor were patient
interactions likely to otherwise affect outcomes. Finally, we must also assume consistency,
that the intervention of assigning treatment at a given time point corresponds with the
exposure classification. We can then write that we observe L1 = L
a0
1 when A0 = a0 and
Y = Y a when A1 = a.
Hence, we have that Q2(l1) = E(Y | A1 = a, L1 = l1) at the realization l1 and Q1(l0) =
E(Q2(l1) | A0 = a0, L0 = l0) at l0, so that both quantities are estimable from the data. And
since E(Y a) = E{Q1(L0)}, the parameter of interest is also identifiable (Bang and Robins,
2005; Petersen et al., 2013). Throughout, a subscript n will be used to denote an estimate
of a quantity. If we sequentially estimate the quantities Q2(l1) and Q1(l0), we can obtain a
plug-in estimator for E(Y a) by taking the mean over the values Q1,n(l0), i.e. the estimates
of Q1(l0) obtained for each subject (Bang and Robins, 2005).
Define g0(l0) = P (A0 = a0 | L0 = l0), the conditional probability of taking treatment a0 at
the beginning of the first trimester. Similarly, define g1(l1) = P (A1 = a1 | L1 = l1, A0 = a0)
as the conditional probability of taking a1 at the beginning of the second trimester. An
inverse probability of treatment weighted estimate for ψ can be taken as the sample average
of Y I(A1 = a)/{g0,n(L0)g1,n(L1)} (Robins et al., 2000) where I(·) is the indicator function.
3.2 Longitudinal targeted minimum loss-based estimation
Longitudinal TMLE (LTMLE) (van der Laan and Gruber, 2012) is a semiparametric esti-
mator that takes initial estimates of Q2(l1) and Q1(l0) and updates them to reduce excess
bias in the estimation of ψ resulting from the use of misspecified models or flexible learning
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algorithms with slower rates of convergence. The form of this update is designed to satisfy the
efficient influence function estimating equation (van der Laan and Rubin, 2006), resulting in
locally efficient and doubly robust estimation of ψ (van der Laan and Robins, 2003) (details
in the Web Appendix A). Below we give the algorithm for a binary outcome and fixed a
though it has been described elsewhere (van der Laan and Gruber, 2012).
Algorithm 1 LTMLE algorithm for two time points
1: Compute Q2,n(l1), the initial estimate of Q2(l1) = E(Y | A1 = a, L1 = l1), for each
subject at their realization l1.
2: Run intercept-free logistic regression Y ∼ ϵ2/{g0,n(L0)g1,n(L1)}+offset[logit{Q2,n(L1)}]
using subjects with A = a. Let ϵ̂2 be the coefficient estimate.





4: Compute Q1,n(l0), the initial estimate of Q1(l0), by regressing Q
∗
2,n(L1) on A0 and L0
and making a prediction for each subject setting A0 = a0 .
5: Run intercept-free logistic regression Q∗2,n(L1) ∼ ϵ̂1/{g0,n(L0)}+ offset[logit{Q1,n(L0)}]
using subjects with A0 = a0. Let ϵ̂1 be the coefficient estimate.





7: Let ψn, the targeted estimate, be the sample mean of Q
∗
1,n(L0) over all subjects.
This procedure results in semiparametric efficient estimation of ψ if both the estimation
of g and Q are consistent where g = (g0, g1) and Q = (Q2, Q1) are defined with respect to a
set of covariates that satisfies equation (1) (van der Laan and Gruber, 2012), i.e. sufficiently
controls for confounding. This estimator is also doubly robust, in the sense that if the estima-
tion of either g or Q is consistent, then the estimator is consistent for the target parameter.
The collaborative double robustness result (van der Laan and Gruber, 2010; Schnitzer et al.,
2016) shows that consistency can also be achieved when both sets of models are incorrectly
specified in a compatible way. We explain further in Section 3.3.
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There are several choices of loss functions to define the error (i.e. risk or lack of fit) of the
TMLE built from this procedure. One example is the logistic log-likelihood loss function,
defined as L(Q)(O) = L2(Q2)(O) + L1(Q1;Q2)(O) where
L2(Q2)(O) =− I(A1 = a)
[
Y log{Q2(L1)}+ (1− Y ) log{1−Q2(L1)}
]
(2)
L1(Q1;Q2)(O) =− I(A0 = a0)×[
Q2(L1) log{Q1(L0)}+ {1−Q2(L1)} log{1−Q1(L0)}
]
. (3)
The empirical error is obtained by evaluating L(Q∗n)(o) for each subject’s observed val-
ues of O and then taking the mean. The loss functions have a sequential validity in the
sense that the expectation of L2(Q2)(O) is minimized at the true Q2(L1) and the expec-
tation of L1(Q1;Q2)(O) indexed by the true Q2 is minimized at the true Q1(L0). Both
have a quadratic dissimilarity such that the distance between the errors at the true and
candidate Q is quadratic, with the second loss component indexed at a fixed value of
Q2 (van der Laan and Gruber, 2010, Section 2.2).
3.3 Longitudinal collaborative double robustness
The general collaborative double robustness result (van der Laan and Gruber, 2010) states
that for doubly robust estimators with componentsQ and g and influence functionD(ψ,Q, g),
the treatment model must only condition on the error in the outcome model predictions in
order to obtain consistent estimation. Suppose that Qn and gn are estimators of Q and g,
respectively, but that Qn and gn converge componentwise in probability to some limits Q̃ and
g̃. We have that E{D(ψ, Q̃, g̃)(O)} = 0 when either Q̃ = Q or g̃ = g. In the two time point
case, given fixed but possibly misspecified estimates Qn = (Q2,n, Q1,n), we are interested
in determining the set of values of g = (g0, g1) that will lead to consistent estimation of
ψ. As in the general case, this corresponds to determining the form of estimates (g0,n, g1,n)
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which converge to g̃ = (g̃0, g̃1) such that E{D(ψ, Q̃, g̃)(O)} = 0. For more details about
convergence, please refer to Web Appendix A.
SinceE{D(ψ,Q, g̃)(O)} = 0 and by linearity of expectations, we can writeE{D(ψ, Q̃, g̃)(O)} =
E{D(ψ, Q̃, g̃)(O)−D(ψ,Q, g̃)(O)} (van der Laan and Gruber, 2010). For the two time point






















Noting the linearity of D(ψ,Q, g) in the components of Q, we can also write
D(ψ, Q̃, g̃)(O)−D(ψ,Q, g̃)(O) = I(A0 = a0)
g̃1(L1)g̃0(L0)
{










We have that the conditional expectation of the second component is zero when g̃0(L0) =
P [A0 = a0 | {Q̃1(L0)−Q1(L0)}]. The conditional expectation of the first component is zero
when we set g̃1(L1) = P [A1 = a1 | {Q̃2(L1)−Q2(L1)}/g̃0(L0), I(A0 = a0)]. Therefore, given
an estimator Qn = (Q2,n, Q1,n) consistent for (Q̃2, Q̃1), if we knew the value of the errors
Q̃1(l0) − Q1(l0) and Q̃2(l1) − Q2(l1), it would be sufficient to adjust for these errors in the
respective treatment models. This would produce consistent inference for any doubly robust
estimator. However, since this error is unknown, C-TMLE targets the reduction of the model
risk (i.e. improves the fit of Qn) by selecting variables into the treatment models that explain
the residual bias Q̃−Q. The longitudinal C-TMLE algorithm is presented in Section 3.4.
3.4 Collaborative selection for the treatment models
Suppose we have defined the error of estimates Qn and gn by specifying respective loss
functions. The concept behind C-TMLE (van der Laan and Gruber, 2010, Section 2.4) is that
the procedure must produce a sequence of targeted estimates represented by {Q∗,(k)n , g(k)n ; k =
1, ..., K} such that the sequence is simultaneously decreasing in the empirical risk of both Q∗n
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and gn. This is achieved by producing an initial estimate Q
init
n and then gradually increasing
the flexibility of the model for g, for instance by selecting covariates or non-linearities in a
greedy stepwise manner, where the error is evaluated on the Q∗n resulting from the TMLE
update. The step k indexes the number of covariates or terms that have been added to
either treatment model. K is defined as the number of moves that results in all of the
covariates or terms added to the models. We assume that at some minimal step km 6 K, we
achieve consistent estimation where g
(km)
n converges to g̃(km) and Q
∗,(km)
n to Q̃∗,(km) such that
E[D{ψ, Q̃∗,(km), g̃(km)}(O)] = 0 (which relaxes the typical assumption that we need to include
all terms in the treatment models for consistent estimation). We also assume that models
past km also allow for consistent estimation (van der Laan and Gruber, 2010, Section 4).
The C-TMLE procedure uses an empirical risk function, evaluated through cross-validation,
to choose the index at which the estimator is selected. For this, we choose a penalized
loss function (Gruber and van der Laan, 2011) L(Q)(O) = L2(Q2)(O) + L1(Q1;Q2)(O) +
V ar{D(ψ,Q, g)(O)}/n where the penalty term is the variance of the efficient influence
function divided by the sample size (see Section 3.4.2 for more intuition). This penalty
term converges to zero, so that the loss function remains asymptotically valid.
3.4.1 Algorithm. A C-TMLE variable selection procedure in the setting with a single
treatment point has been described in Gruber and van der Laan (2011). We describe a
similar procedure for two treatment points for the estimation of ψ = E(Y a) (generalized
for larger numbers of time points in the Web Appendix B) which we call Collaborative
Longitudinal TMLE (C-LTMLE). We define the operation update(Qn, gn) as the procedure
that takes initial estimates Qn = (Q2,n, Q1,n) and updates them separately using the LTMLE







as described in Section 3.2. Define “allowable moves” as the set of remaining additions of
covariates or terms to the existing models for g0 and g1. We restrict such moves by only
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allowing variables in L0 to be selected for g0, but any of L1 allowed into the model for g1.
Finally, define the notation g
(k−1)
n (m) as the probability of treatment estimates using the
models from step k− 1 after additional move m (that is, after adding a covariate or term to
either model according to move m).
Algorithm 2 C-LTMLE candidate building procedure
1: Initialize g
(0)
n and QBn := Q
(init)
n ; and set Q
∗,(0)
n := update{Q(init)n , g(0)n }; and l0 :=
mean(L{Q∗,(0)n }).
2: for k = 1, ..., K where K is total number of allowable moves do
3: Select move m that results in the lowest error in the updated estimate
mean(L[update{QBn , g
(k−1)
n (m)}]). Call this minimum error lk.
4: if lk > lk−1 then
5: Set QBn := update{QBn , g
(k−1)
n }, the new baseline estimate.
6: Select move m that results in the lowest error in the updated estimate
mean(L[update{QBn , g
(k−1)





















n that are improving in fit by construction. Cross-validation of the full
procedure is used to select the step km,n, dependent on sample size, at which the procedure
should terminate. We thus obtain the final vector of predictions, Q
∗,(km,n)
2,n which is used to





1,n . The C-LTMLE estimate ψ
CLTMLE
n is then computed as the mean of Q
∗,(km,n)
1,n over
all subjects. In the Web Appendix C, we provide intuition for why this procedure would be
likely to select covariates in a way that improves the estimation of the target parameter.
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3.4.2 Properties. With a valid loss function (with corresponding risk minimized at the
truth and possessing a quadratic dissimilarity), the cross-validation selector converges to
an oracle selector (which picks the Q
∗,(k)
n closest to the true Q with respect to the loss
function) at a rate of log(n)/n (van der Laan and Dudoit, 2003). A reduction in error of
Qn implies a less biased plug-in estimate. In C-TMLE, because we are selecting amongst
TMLEs targeting the same ψ with the same initial estimate Q
(init)
n , the cross-validation
selects the best update step indexed by k. Because overfit treatment models may result
in increased variance, the penalized loss function may select an index prior to km in finite
samples, which allows the procedure to trade off between reduced bias and variance. The
asymptotic linearity of C-TMLE, which is justified in van der Laan and Rose (2011, A.18),
relies on the convergence of the cross-validation selector to some step k between km and K.




n , k > km allow for TMLE convergence at the
√
n-rate as described for LTMLE in the Web Appendix A. The specific form of the influence
function depends on the convergence of the selected g
(k)
n to conditional distribution g̃(k).
If g̃(k) = g the influence function of the C-LTMLE will not involve any contribution from




n ) will be oP (1/
√
n) in the L2(P ) norm. If not, the
influence function may include a component related to Q
∗,(k)
n (van der Laan and Rose, 2011,
A.18). In the simulation study and the example, we approximate the large-sample variance
of C-LTMLE using the efficient influence function evaluated with the largest (i.e. unselected)
model for g.
4. Simulation study
The performance of this estimator was assessed in a simple setting, a setting with a large
number of correlated covariates, and a setting with nonlinear terms and the potential for
practical positivity violations, respectively. For each data generation, 1000 independent
draws of identically distributed longitudinal data with binary treatments were generated
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with sample sizes n = {250, 500, 1000}. The full data-generation for the three settings is
given in the Web Appendix D and summarized below.
In all simulations, we contrast G-Computation (a plug-in estimator that uses the initial esti-
mates ofQ2 andQ1 without TMLE updates) (Bang and Robins, 2005), IPTW (Robins et al.,
2000), Longitudinal TMLE, and C-LTMLE (Section 3.4) implemented with logistic regres-
sions for simplicity. We also apply what we refer to as C-IPTW, which is the C-LTMLE
algorithm applied to a completely misspecified initial estimate Q2,n = En(Y |A0 = a0, A1 =
a1) from a model that does not adjust for any additional covariates. In this version of the
algorithm, the model estimating Q1,n = En(Q2,n | A0 = a0) is also fit without covariates
aside from treatment A0. C-IPTW was included to investigate how C-LTMLE might correct
for a severely misspecified outcome model. We present the root mean squared errors (rMSE),
mean bias, and Monte-Carlo standard errors (MC SE) for each estimator.
For variance estimation for C-IPTW and the TMLE methods, we applied the full-model
influence curve sandwich estimator and a targeted variance estimator (Tran, 2016) imple-
mented in the ltmle package, version 1.0-1 (Lendle et al., 2017). For G-Computation we
applied the nonparametric bootstrap. We computed the average of the estimated standard
errors SEIC , SETE, and SEB, respectively. For the first two approaches, the 95% confidence
intervals were computed as the point estimate ±1.96× SE and for the latter as the 5th and
95th percentiles of the bootstrap-resampled estimates. We present the percentage of interval
coverage across the simulations (%Cov) for each method. All computations were carried out
using R statistical software version 3.2.0 (R Development Core Team, 2011).
4.1 Simple setting
The twofold purpose of this first setting is to verify that the C-LTMLE algorithm is selecting
covariates in a manner consistent with the known variable selection recommendations in
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causal inference (face validity), and to contrast the performance of the alternative algorithms
in a familiar setting (Brookhart et al., 2006).
We independently sampled data O = (L0, A0, L1, A1, Y ) in sequence. The independent
Gaussian baseline covariates L0 = (IV0, R0,W0) included an instrument IV0 (that only
affected binary treatment choices A0 and A1), a variable R0 that is not a confounder but
affects the binary outcome Y , and a baseline confounder W0 (directly affecting A0, L1,
and Y ). The Gaussian covariates L1 = (IV1, R1,W1) at the next time point included an
instrument IV1 (only affecting treatment choice A1), a variable R1 that only affects the
outcome, and a time-dependent confounder W1 (affecting A1 and Y ) influenced by previous
treatment A0. The target parameter is the mean outcome under treatment, E{Y 1,1} = 0.286.
By design there is no potential for practical positivity violations, so one would expect an
optimal method to select the confounders and omit the instruments.
All of the models were specified on the full set of covariate histories. Table 1 gives the results
from each of the five evaluated methods. G-Computation, which was implemented with a
regression conditional on all covariates, was unbiased and outperformed all other methods
in terms of variance. IPTW conditional on all covariates maintained some bias and had the
largest MC SE. C-IPTW had half of the variance of IPTW and smaller bias for the larger
sample sizes. LTMLE was unbiased and had smaller variance than C-IPTW. C-LTMLE had
a MC SE that rivaled G-Computation and was also unbiased, outperforming LTMLE for
the smaller sample sizes. In terms of standard error estimation, the bootstrap performed
well for G-Computation. The influence curve method performed well for C-LTMLE but
underestimated the MC SE for LTMLE, and C-IPTW at smaller sample sizes. The targeted
estimator consistently overestimated the standard errors for C-IPTW, LTMLE, and C-
LTMLE, leading to confidence interval coverage around 99%, and underestimated for IPTW
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at n = 1, 000. In the Web Table 1, we show that the C-LTMLE selected the confounders
100% of the time for the larger sample size and non-confounders between 10-30% of the time.
[Table 1 about here.]
4.2 Correlated covariates
This scenario evaluates the performance of C-LTMLE with a large number of correlated
covariates. We generated 40 baseline multivariate Gaussian covariates with pairwise covari-
ances equal to 0.2 and variances equal to one. Ten of these covariates were confounders,
ten were also confounders but more strongly related to the treatment than the outcome,
ten were purely risk factors, and ten had no direct effects on either (noise). An additional
ten intermediate Gaussian covariates were then generated conditional on the baseline and
treatment A0; five of these were confounders, two were more strongly related to treatment,
and three only caused the outcome. We generated a binary outcome conditional on the
treatments and non-noise baseline and intermediate covariates. The true value of the target
parameter was E(Y 1,1) = 0.622.
Table 2 gives the results of the five methods. All outcome models were specified using
logistic regression conditional on all 50 covariates. G-Computation had the least variance
overall but the greatest bias, resulting in poor coverage. IPTW was unbiased but had a much
greater MC SE than G-Computation. C-IPTW performed similarly to IPTW, though its MC
SE was smaller for n = 250. LTMLE and C-LTMLE were unbiased and C-LTMLE had lower
MC SE for the smaller samples. In terms of standard error estimation, the influence curve
method performed well for LTMLE and C-LTMLE, resulting in good coverage for the larger
sample sizes, though it underestimated the true standard error for C-IPTW. The targeted
method performed well for IPTW and overcovered slightly for LTMLE and C-LTMLE.
[Table 2 about here.]
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4.3 Continuous outcome with potential practical positivity violations
We extended the simulation study of (Bahamyirou et al., 2018) to the two time point setting.
The concept of this scenario is that there are interaction and squared terms between covari-
ates in the data-generating functions for the two treatments, but these nonlinearities are not
confounding the relationship between treatments and the continuous outcome. Furthermore,
the probabilities of treatment are close to zero when conditional on the true interactions
and squared terms, and far from zero when excluding the nonlinearities. Thus, excluding
these features should not affect consistency and will avoid practical positivity violations.
We consider that the analyst intends to use C-TMLE to select amongst main terms and
nonlinearities in ignorance of the consistency under a much smaller (main terms only)
treatment model. One would expect optimal performance using a method that a priori
excludes these nonlinearities. C-LTMLE would ideally be able to adaptively exclude them
and perform similarly.
We generated five baseline covariates: two instruments, one pure cause of the outcome
and intermediate confounders, and two confounders. At the second time point, we generated
two additional confounders. The treatment and outcome data-generating functions included
main terms, interactions, and squared terms though no nonlinearities were common between
the two. We implemented G-Computation, IPTW, LTMLE, and C-LTMLE including all
main, squared, and interaction terms (20 in L0 and 15 in L1). We also implemented IPTW
and LTMLE using just the main terms. C-IPTW and C-LTMLE selected from the full set
of possible terms (55 selection steps). To coincide with current practice, each probability of
treatment was truncated at 0.01 (Lendle et al., 2017).
Table 3 gives the results of each method in this scenario. The G-Computation fit using a
logistic regression that included all possible nonlinearities maintained a low bias and variance
for all sample sizes. In contrast, the IPTW that included the same terms had bias and MC
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SE that were one magnitude larger. When the IPTW included only the main terms, the
bias was nearly eliminated and the variance greatly reduced. LTMLE outperformed the
corresponding IPTW estimators in terms of variance when including all terms and just main
terms, respectively. The C-IPTW improved upon the estimation of IPTW, roughly quartering
the variance but maintaining the magnitude of bias. The C-LTMLE performed slightly better
in terms of bias and MC SE than the LTMLE with main terms for n = 250 but maintained its
bias as the sample size increased. The influence curve approach underestimated the standard
error of LTMLE with the full model, and overestimated that of LTMLE with main terms
only, resulting in good coverage for the latter. The targeted variance estimation method
performed well for IPTW with main terms. The bootstrap produced reasonable standard
error estimates for G-Computation. For other models, these standard error estimates did
not correspond to the MC SE on average. Confidence interval coverage was low overall due
to this issue and to estimation bias for all methods except LTMLE with main terms.
[Table 3 about here.]
5. Estimating the effect of inhaled corticosteroids during pregnancy
The C-LTMLE method described above was applied to estimate the effect of taking low daily
doses of ICS during pregnancy in women categorized with mild asthma in the year prior to
pregnancy. Mild asthma was categorized using an algorithm previously validated in this
population (Cossette et al., 2013). Women were considered exposed to low ICS daily doses
(< 250µg in Fluticasone equivalent) at the beginning of the first trimester (A0 = 1) if they
had begun a prescription by the beginning of pregnancy. As summarized in Section 2, there
are 18 baseline and 19 intermediate measured variables, leading to a total of 110 possible
covariate additions to the four treatment models. All three of the outcomes investigated
(LBW, premature birth, and SGA) are binary perinatal risk indicators. Therefore, we seek
18 Biometrics, Xxxx xxxx
to estimate the marginal risk ratio under exposure to low-dose ICS at the beginning of both
trimesters versus neither, E(Y 1,1)/E(Y 0,0). This parameter is greater than 1 if adherence to
low daily doses of ICS increases the probability of the outcome and is therefore hazardous
to the fetus.
An additional complication in this dataset that was not previously mentioned is the
presence of censoring. We considered all women in the cohort who were not taking either
treatment category of interest (for instance, those taking higher daily doses) to be censored.
We indicate C0 = 1 if a woman is censored at the beginning of the first trimester (and C0 = 0
otherwise), and C1 = 1 if a woman is censored at the beginning of the second trimester
(C1 = 0 otherwise). In particular, if C0 = 1 then C1 = 1 for the same individual. We
therefore have the full observed dataset O = (L0, C0, A0, L1, C1, A1, Y ) where once censored,
all subsequent values of L,A and Y are considered to be missing. In order to adjust for
potentially informative censoring in addition to the confounded treatment, we must break
g into two components. In particular, we redefine g0 = gA,0 × gC,0 and g1 = gA,1 × gC,1
where now gA,0(l0) = P (A0 = a0 | L0 = l0, C0 = 0) and gA,1(l1) = P (A1 = a1 | L1 =
l1, A0 = a0, C1 = 0) are the treatment probabilities and gC,0(l0) = P (C0 = 0 | L0 = l0)
and gC,1(l1) = P (C1 = 0 | L1 = l1, A0 = a0, C0 = 0) are the censoring probabilities. In the
C-LTMLE algorithm, this allows for the possibility of adding the eligible covariates into both
the treatment and censoring models separately, increasing the number of possible additions
at every step. Otherwise, the procedure as described above remains unchanged.
We contrasted the results of G-Computation, IPTW, LTMLE, and C-LTMLE, run sepa-
rately for a = (1, 1) and a = (0, 0), for the estimation of the marginal risk ratio. For each
of the three outcomes, G-Computation, LTMLE and C-LTMLE used the same outcome
model, fit with a main terms logistic regression. Treatment probabilities were truncated to
lie between (0.01,0.99) in all cases. The variances of LTMLE and C-LTMLE were calculated
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using the standard sandwich estimator which uses the efficient influence function with the full
(unselected) treatment models and the functional delta method (van der Laan and Gruber,
2012). At the time of writing, the targeted variance estimation method was not available for
saturated contrasts in the ltmle package. The variances of G-Computation and IPTW were
calculated using the nonparametric bootstrap with 1,000 resamples. All calculations were
carried out in R statistical software version 3.1.3 (R Development Core Team, 2011).
The results for the three outcomes and four methods are presented in Table 4. The risk
ratio estimates, 95% confidence intervals, and standard errors (SE) are reported. The number
of variables selected by C-LTMLE are reported for each exposure category. Truncation
was found to be necessary for IPTW and LTMLE, and likely beneficial for C-LTMLE,
due to the otherwise large weights. Similarly to related analyses of low dose versus no
ICS (Cossette et al., 2013), all three outcomes had risk ratios that were close to one with
confidence intervals that contained the null. The usage of C-TMLE only slightly altered
the risk ratios compared to LTMLE. In terms of computation time on a local server, G-
Computation (with bootstrapping) took 720 seconds, IPTW (with bootstrapping) took 1450
seconds, LTMLE took 1 second, and the C-LTMLE cross-validation procedure took 8670
seconds. We comment on the credibility of the causal assumptions in the Web Appendix E.
[Table 4 about here.]
6. Discussion
In this paper, we developed a collaborative longitudinal targeted minimum loss-based esti-
mation (C-LTMLE) approach for time-varying treatments. This method sequentially selects
terms to be included in the treatment (and/or censoring) models that are used in the TMLE
update steps. This selection is decided by a penalized loss function for the updated nested
conditional expectations of the outcome. Related work for dynamic treatment regimes by
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Shi et al. (2018) involves a high-dimensional covariate selection method constrained by a
doubly-robust estimating equation that involves the product of the errors of the estimated
time-specific probability of treatment and nested outcome expectation. Rather than using
cross-validation to select the tuning parameter as we do, their method uses a doubly robust
Bayesian information criterion. Another difference is that TMLE methods do not require any
assumed model structure for the treatment(s) or outcome, though they still require regularity
conditions and minimal convergence rates.
Our procedure can be adapted for non-saturated marginal structural models using Pooled
Longitudinal TMLE (Petersen et al., 2013). Since selection steps in the given procedure
require testing all possible additions to each treatment model, the computational complexity
is a concern for a large number of time points. One may potentially adapt the a priori variable
ordering in Ju et al. (2017) to the longitudinal setting to reduce computational time.
In the simulation study, C-LTMLE performed better than other semiparametric methods,
but worse than the fully parametric (slightly misspecified) G-Computation for n < 1, 000, in
terms of standard error and bias in the three scenarios. In the first simulation, we observed
that C-LTMLE selected covariates in a way that roughly corresponded to common knowledge
in causal inference, selecting true confounders 100% of the time for larger sample sizes
and including instruments and pure causes of the outcome at similar rates around 10-30%.
More empirical investigation may be required to better understand how C-TMLE prioritizes
covariates in practice. In the third scenario, C-LTMLE was able to greatly reduce the bias and
variance compared to the LTMLE that included all unnecessary nonlinear terms. However,
the residual bias did not decrease as the sample size increased, though the Monte Carlo
variance did. Variance estimation for C-LTMLE was done using both the standard influence
curve approach and a robust targeted method (Tran, 2016), evaluated with the full model
for g. The influence curve approach performed well for C-LTMLE under the two larger
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sample sizes investigated and the targeted approach overestimated in the simple setting
with few covariates (as it did for LTMLE). Neither approach performed well in the presence
of positivity violations. For C-LTMLE, this was likely because the cross-validation selector
omitted true terms in the g-model, resulting in an influence function that depended on the
estimation of Q. Future work is needed to investigate post-selection issues in C-TMLE and
variance estimation under misspecification.
The application involved the estimation of the perinatal safety of taking a low dose of
inhaled corticosteroids (ICS) in the first two trimesters of pregnancy in women with mild
asthma. Missing outcome data required that censoring models be added to the C-LTMLE
procedure. No methods suggested that there is an effect on low birth weight, having a
preterm birth, or delivering a baby with a weight in the lowest 10th percentile. The C-
LTMLE slightly shifted the point estimates for the two latter outcomes but this did not
change the interpretation. The sandwich variance estimate for C-LTMLE was greater than
the bootstrapped estimate for the G-Computation and much less than that of IPTW.
By introducing our Longitudinal C-TMLE approach, we hope to stimulate development
and discussion of variable selection methods for saturated and unsaturated marginal struc-
tural models. Without variable or model selection approaches, fitting the required models
may prove challenging in areas where the number of potential time-varying confounders is
large. The improvement of such techniques is likely to facilitate the adoption of longitudinal
causal inference methods in substantive research areas.
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application and data. This work was supported by the National Sciences and Engineering
Research Council of Canada (A Discovery Grant and Accelerator Supplement to MES),
the Canadian Institutes of Health Research (New Investigator Salary Award to MES), the
22 Biometrics, Xxxx xxxx
Canadian Network for Observational Drug Effect Studies (funding support for SFG), and
the Faculty of Pharmacy of Université de Montréal.
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Table 1
Simple scenario simulation study results. Root mean squared error, mean bias, Monte Carlo standard error, and
estimated standard error and coverage. SEIC is calculated from the influence curve; SETE is the TMLE estimate of
the standard error from the ltmle package. All models are specified on the full sets of covariate histories. True value
E(Y 1,1) = 0.286.
GCOMP IPTW C-IPTW LTMLE C-LTMLE
n = 250
rMSE 0.045 0.165 0.090 0.076 0.055
Mean Bias -0.002 -0.019 -0.036 -0.007 -0.005
MC SE 0.045 0.164 0.083 0.076 0.055
SEIC(%Cov) - - 0.069(78) 0.057(78) 0.057(91)
SETE(%Cov) - 0.213(93) 0.213(98) 0.160(99) 0.160(99)
SEB(%Cov) 0.044(94) - - - -
n = 500
rMSE 0.031 0.125 0.059 0.055 0.038
Mean Bias 0.001 -0.023 -0.012 -0.001 -0.001
MC SE 0.031 0.123 0.058 0.055 0.038
SEIC(%Cov) - - 0.052(87) 0.043(82) 0.043(95)
SETE(%Cov) - 0.122(91) 0.122(99) 0.090(99) 0.090(100)
SEB(%Cov) 0.031(95) - - - -
n = 1, 000
rMSE 0.022 0.107 0.037 0.041 0.026
Mean Bias -0.001 -0.018 -0.007 -0.003 -0.002
MC SE 0.022 0.106 0.037 0.040 0.026
SEIC(%Cov) - - 0.040(93) 0.033(83) 0.033(97)
SETE(%Cov) - 0.085(84) 0.085(99) 0.061(99) 0.061(100)
SEB(%Cov) 0.021(95) - - - -
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Table 2
Correlated covariates simulation study results. Root mean squared error, mean bias, Monte Carlo standard error,
and estimated standard error and coverage. SEIC is calculated from the influence curve; SETE is the TMLE
estimate of the standard error from the ltmle package. True value E(Y 1,1) = 0.622.
GCOMP IPTW C-IPTW LTMLE C-LTMLE
n = 250
rMSE 0.051 0.158 0.095 0.086 0.069
Mean Bias -0.025 -0.010 0.029 0.002 0.001
MC SE 0.044 0.158 0.090 0.086 0.069
SEIC(%Cov) - - 0.078(84) 0.064(79) 0.064(89)
SETE(%Cov) - 0.185(94) 0.185(99) 0.152(98) 0.152(98)
SEB(%Cov) 0.047(94) - - - -
n = 500
rMSE 0.039 0.065 0.073 0.051 0.045
Mean Bias -0.025 -0.004 0.007 -0.003 -0.004
MC SE 0.030 0.065 0.072 0.051 0.045
SEIC(%Cov) - - 0.053(83) 0.047(91) 0.047(95)
SETE(%Cov) - 0.066(95) 0.066(93) 0.056(96) 0.056(98)
SEB(%Cov) 0.031(87) - - - -
n = 1, 000
rMSE 0.031 0.037 0.051 0.033 0.030
Mean Bias -0.022 0.000 -0.006 0.003 0.000
MC SE 0.021 0.037 0.050 0.033 0.030
SEIC(%Cov) - - 0.036(82) 0.033(94) 0.033(95)
SETE(%Cov) - 0.040(96) 0.040(86) 0.035(97) 0.035(97)
SEB(%Cov) 0.021(83) - - - -
Longitudinal model selection with C-TMLE 29
Table 3
Continuous outcome with potential practical positivity violations simulation study results. All models are fit on the
full data, including main terms, first-order interactions, and squared terms with the exception of IPTWMT and
LTMLEMT which include models fit on the main terms only. The collaborative methods select from all main terms,
first-order interactions, and squared terms. Root mean squared error, mean bias, Monte Carlo standard error, and
mean estimated standard error were exceptionally calculated with 10% trimmed means due to outliers. SEIC is
calculated from the influence curve; SETE is the TMLE estimate of the standard error from the ltmle package. True
value E(Y 1,1) = 10.39.
GCOMP IPTW IPTWMT C-IPTW LTMLE LTMLEMT C-LTMLE
n = 250
rMSE 0.53 4.55 1.00 2.22 2.53 0.78 0.65
Mean Bias -0.32 -2.27 -0.15 2.13 1.32 -0.22 0.21
MC SE 0.44 4.26 0.99 0.77 2.37 0.74 0.66
SEIC(%Cov) - - - 0.99(43) 0.72(34) 0.98(92) 0.72(86)
SETE(%Cov) - 0.85(25) 1.04(90) 0.87(35) 0.56(32) 0.94(91) 0.56(82)
SEB(%Cov) 0.53(90) - - - - - -
n = 500
rMSE 0.45 4.42 0.74 2.15 1.62 0.53 0.56
Mean Bias -0.32 -2.90 -0.12 2.11 0.89 -0.10 0.26
MC SE 0.35 3.72 0.73 0.54 1.51 0.52 0.54
SEIC(%Cov) - - - 0.84(31) 0.50(43) 0.84(96) 0.50(82)
SETE(%Cov) - 0.71(21) 0.78(91) 0.71(22) 0.42(42) 0.80(93) 0.42(77)
SEB(%Cov) 0.38(82) - - - - - -
n = 1, 000
rMSE 0.36 4.12 0.55 2.13 1.20 0.40 0.50
Mean Bias -0.30 -3.29 -0.08 2.11 0.68 -0.09 0.27
MC SE 0.23 2.88 0.54 0.38 1.10 0.39 0.47
SEIC(%Cov) - - - 0.75(17) 0.37(47) 0.67(96) 0.37(80)
SETE(%Cov) - 0.59(20) 0.58(91) 0.58(10) 0.31(45) 0.64(94) 0.31(75)
SEB(%Cov) 0.27(79) - - - - - -
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Table 4
Application results for longitudinal C-LTMLE, LTMLE, IPTW, and G-Computation, implemented with logistic
regressions. The parameter estimated is E(Y 1,1)/E(Y 0,0). n = 5, 048
Outcome GCOMP IPTW LTMLE C-LTMLE
SGA
Estimate 1.02 1.02 1.05 1.02
SEIC 0.09 0.16 0.10 0.10
95% CI (0.87,1.21) (0.71,1.30) (0.86,1.25) (0.83,1.20)
n. vars selected {(1, 1), (0, 0)} - - - (0,0)
Premature
Estimate 1.00 0.91 0.94 0.97
SEIC 0.10 0.16 0.11 0.12
95% CI (0.81,1.22) (0.76,1.38) (0.72,1.16) (0.73,1.20)
n. vars selected {(1, 1), (0, 0)} - - - (35,35)
LBW
Estimate 1.11 1.07 1.10 1.13
SEIC 0.13 0.18 0.14 0.14
(95% CI) (0.90,1.41) (0.81,1.55) (0.83,1.38) (0.86,1.41)
n. vars selected {(1, 1), (0, 0)} - - - (31,0)
